These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7811936)

  • 21. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-incorporation of A beta 40 and A beta 42 to form mixed pre-fibrillar aggregates.
    Frost D; Gorman PM; Yip CM; Chakrabartty A
    Eur J Biochem; 2003 Feb; 270(4):654-63. PubMed ID: 12581205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of aggregation of synthetic beta-amyloid peptide.
    Tomski SJ; Murphy RM
    Arch Biochem Biophys; 1992 May; 294(2):630-8. PubMed ID: 1567217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril.
    Konno T
    Biochemistry; 2001 Feb; 40(7):2148-54. PubMed ID: 11329283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
    Otvos L; Szendrei GI; Lee VM; Mantsch HH
    Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aluminium, beta-amyloid and non-enzymatic glycosylation.
    Exley C; Schley L; Murray S; Hackney CM; Birchall JD
    FEBS Lett; 1995 May; 364(2):182-4. PubMed ID: 7750567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution.
    Massi F; Peng JW; Lee JP; Straub JE
    Biophys J; 2001 Jan; 80(1):31-44. PubMed ID: 11159381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of electrokinetic and hydrodynamic global properties of relevant amyloid-beta peptides through the modeling of their effective electrophoretic mobilities and analysis of their propensities to aggregation.
    Deiber JA; Piaggio MV; Peirotti MB
    J Sep Sci; 2014 Sep; 37(18):2618-24. PubMed ID: 24975363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
    Benseny-Cases N; Klementieva O; Cladera J
    Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
    Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
    J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
    Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
    Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A biotechnological method provides access to aggregation competent monomeric Alzheimer's 1-42 residue amyloid peptide.
    Döbeli H; Draeger N; Huber G; Jakob P; Schmidt D; Seilheimer B; Stüber D; Wipf B; Zulauf M
    Biotechnology (N Y); 1995 Sep; 13(9):988-93. PubMed ID: 9636276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.
    Shao H; Jao S; Ma K; Zagorski MG
    J Mol Biol; 1999 Jan; 285(2):755-73. PubMed ID: 9878442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway.
    Di Carlo MG; Minicozzi V; Foderà V; Militello V; Vetri V; Morante S; Leone M
    Biophys Chem; 2015 Nov; 206():1-11. PubMed ID: 26100600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global properties and propensity to dimerization of the amyloid-beta (12-28) peptide fragment through the modeling of its monomer and dimer diffusion coefficients and electrophoretic mobilities.
    Deiber JA; Peirotti MB; Piaggio MV
    Electrophoresis; 2015 Mar; 36(5):805-12. PubMed ID: 25403948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.
    Gorman PM; Chakrabartty A
    Biopolymers; 2001; 60(5):381-94. PubMed ID: 12115148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.